Jinle Han

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Fengcai Zhu, Chunlan Zhuang, Kai Chu et al. · The Lancet Respiratory Medicine · 2022 · 138 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Junyu Chen, Pui Wang, Lunzhi Yuan et al. · Science Bulletin · 2022 · 127 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Generation of Murine CTL by a Hepatitis B Virus-Specific Peptide and Evaluation of the Adjuvant Effect of Heat Shock Protein Glycoprotein 96 and Its Terminal Fragments

Hongtao Li, Minghai Zhou, Jinle Han et al. · The Journal of Immunology · 2005 · 81 citations

Life Sciences, Immunology, Infectious Diseases +17

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Fei Ju, Yong Luo, Chaolong Lin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Fengcai Zhu, Shoujie Huang, Xiaohui Liu et al. · The Lancet Respiratory Medicine · 2023 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17